Skip to main content
Article thumbnail
Location of Repository

Cytokeratin and mammaglobin as tumor markers in patients with high risk breast cancer

By PF Ferrucci, C Rabascio, C Corsini, F Tealdo, M Paolucci, F Bertolini, H El Taani and G Martinelli
Topics: Meeting Abstract
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:3300870
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (1997). et al: Cancer Epidemiol Biomarkers Prev
    2. (1991). et al: Nucleic Acids Res
    3. Genes Chromosomes Cancer 1992, 5:89–90. PIV-07 P53 mutations in breast and ovarian carcinomas from BRCA1 and 2 mutation carriers and noncarriers
    4. (1998). methods: Patients were enrolled from
    5. (1993). Oncogene
    6. PIV-09 Constitutional alterations of the ATM gene in early-onset sporadic breast cancer
    7. PIV-10 Modulation of ATM gene expression in a murine mammary epithelial cell line
    8. PIV-15 A detailed physical map of a region within human chromosome 16q22.1
    9. (1994). PVII-03 Does a polymorphism in the CYP17 gene predict mammographic
    10. PVII-04 Ribozymes targeting the tumor suppressor BRCA1 lead to increased chemosensitivity to cisplatin and etoposide and chemoresistance to microtubule-interfering agents in HBL100 breast cancer cell line
    11. PVIII-09 Expression profiling of BRCA1 associated breast tumors
    12. (2000). PVIII-10 Transcript profiles and genotyping of cancer tissue
    13. (1990). Saya H: Nucleic Acids Res

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.